The PoNS® Device
The PoNS device is an innovative technology to help individuals with chronic neurological symptoms of disease or trauma. It includes a controller and mouthpiece that delivers mild stimulation to the surface of the tongue. This stimulation triggers a flow of neural impulses to the brain structures that control motor function. Use of the device while engaging in movement and coordination tasks promotes neuromodulation and neuroplasticity, activating brain pathways to improve function.
PoNS used in conjunction with supervised therapeutic exercises is referred to as PoNS Therapy™.
The PoNS is an authorized medical device in the US. The PoNS device is indicated for use as a short-term treatment of gait deficit due to mild to moderate symptoms from multiple sclerosis (MS) and is to be used as an adjunct to a supervised therapeutic exercise program in patients aged 22 and older by prescription only.
PoNS™ is an authorized medical device commercially available in Canada intended for use as a short-term treatment (14 weeks) of gait deficit due to mild to moderate symptoms from MS and is to be used in conjunction with physical therapy. The device is also intended for use as a short-term treatment (14 weeks) of chronic balance deficit due to mild to moderate traumatic brain injury (mmTBI) and is to be used in conjunction with physical therapy.
PoNS® is authorized in Australia (AUS TGA) as a non-implantable neurostimulator intended for short-term use by healthcare professionals as an adjunct to a therapeutic exercise program to improve balance and gait. It is not yet commercially available.
What real patients are saying*
*Individual results and experiences may vary. Testimonials are from Canadian residents. PoNS® was authorized for use in the US in March 2021. PoNS Therapy™ has been authorized in Canada since 2018.